FRANKENIUS EQUITY AB reported 1 transaction at TRISALUS LIFE SCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/20/2026ACC: 0001628280-26-026014
10% Owner
Since Aug 2023
+529K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
759K acquired · 230K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+759K
Price / share
—
Trade value
—
% of position
12.2%
7/31/2025
6.23M→6.99M
Total
Net shares
+759K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2025 | C · Conversion | +759K | — | — | 12.2% | 6.23M | 6.99M |
| Total | +759K | $0.00 | ||||||
Derivative Transactions1
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
759K shares
Shares
−230K
Strike price
4
Held after
0.00
Exercisable
—
7/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock759K shares | 7/31/2025 | C · Conversion | −230K | 4 | — | 0.00 |